CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (LOSS) - USD ($) shares in Millions, $ in Millions	12 Months Ended
	Dec. 31, 2015	Dec. 31, 2014	Dec. 31, 2013
CONSOLIDATED STATEMENTS OF INCOME AND COMPREHENSIVE INCOME (LOSS)
Product revenue	$ 1,381.1	$ 1,571.9	$ 1,611.4
Service revenue	235.5	231.8	219.3
Other revenue	7.2	5.2	8.7
Total revenue	1,623.8	1,808.9	1,839.4
Cost of product revenue	774.2	896.0	891.7
Cost of service revenue	139.7	149.6	142.5
Cost of other revenue	1.3
Total cost of revenue	915.2	1,045.6	1,034.2
Gross profit	708.6	763.3	805.2
Operating expenses:
Selling, general and administrative	392.2	451.0	437.9
Research and development	145.7	174.2	190.5
Impairment of assets	4.6	11.5
Other charges, net	20.4	21.2	28.6
Total operating expenses	562.9	657.9	657.0
Operating income	145.7	105.4	148.2
Interest and other income (expense), net	(17.7)	(4.1)	(23.6)
Income before income taxes and noncontrolling interest in consolidated subsidiaries	128.0	101.3	124.6
Income tax provision	23.1	41.7	42.8
Consolidated net income	104.9	59.6	81.8
Net income attributable to noncontrolling interest in consolidated subsidiaries	3.3	2.9	1.7
Net income attributable to Bruker Corporation	$ 101.6	$ 56.7	$ 80.1
Net income per common share attributable to Bruker Corporation shareholders:
Basic (in dollars per share)	$ 0.60	$ 0.34	$ 0.48
Diluted (in dollars per share)	$ 0.60	$ 0.33	$ 0.48
Weighted average common shares outstanding:
Basic (in shares)	168.2	167.8	166.5
Diluted (in shares)	169.1	169.5	168.5
Consolidated net income	$ 104.9	$ 59.6	$ 81.8
Foreign currency translation adjustments	(63.8)	(131.7)	27.3
Pension liability adjustments (net of tax of $2.1 million, $6.5 million and $4.6 million, respectively)	(9.6)	(22.6)	17.3
Net comprehensive income (loss)	31.5	(94.7)	126.4
Less: Comprehensive income attributable to noncontrolling interests	2.3	2.8	1.6
Comprehensive income (loss) attributable to Bruker Corporation	$ 29.2	$ (97.5)	$ 124.8